Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.

Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA, BIG 3–07/TROG 07.01 trial investigators

Open source

DOI: 10.1016/s0140-6736(22)01246-6
Published: 2022 Aug 6
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-22-01246-6,
  title = {Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.},
  author = {Chua BH and Link EK and Kunkler IH and Whelan TJ and Westenberg AH and Gruber G and Bryant G and Ahern V and Purohit K and Graham PH and Akra M and McArdle O and O'Brien P and Harvey JA and Kirkove C and Maduro JH and Campbell ID and Delaney GP and Martin JD and Vu TTT and Muanza TM and Neal A and Olivotto IA and BIG 3–07/TROG 07.01 trial investigators},
  year = {2022},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(22)01246-6},
  url = {https://doi.org/10.1016/s0140-6736(22)01246-6}
}

RIS

TY  - JOUR
TI  - Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
AU  - Chua BH
AU  - Link EK
AU  - Kunkler IH
AU  - Whelan TJ
AU  - Westenberg AH
AU  - Gruber G
AU  - Bryant G
AU  - Ahern V
AU  - Purohit K
AU  - Graham PH
AU  - Akra M
AU  - McArdle O
AU  - O'Brien P
AU  - Harvey JA
AU  - Kirkove C
AU  - Maduro JH
AU  - Campbell ID
AU  - Delaney GP
AU  - Martin JD
AU  - Vu TTT
AU  - Muanza TM
AU  - Neal A
AU  - Olivotto IA
AU  - BIG 3–07/TROG 07.01 trial investigators
PY  - 2022
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(22)01246-6
UR  - https://doi.org/10.1016/s0140-6736(22)01246-6
ER  -

APA

BH, C., EK, L., IH, K., TJ, W., AH, W., G, G., G, B., V, A., K, P., PH, G., M, A., O, M., P, O., JA, H., C, K., JH, M., ID, C., GP, D., JD, M., TTT, V., TM, M., A, N., IA, O., & investigators, B. 3. 0. T. (2022). Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(22)01246-6

Source records

pubmed · retrieved 2026-09-26T07:10:47.016Z